Farther Finance Advisors’s Aldeyra Therapeutics ALDX Stock Holding History

Farther Finance Advisors’s Portfolio ALDX Stock Details ALDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.87K	Sell	3,960 -537	-12%	-$858	﹤0.01%	5026
2026 Q2	$9.57K	Buy	4,497 +47	+1%	+$81	﹤0.01%	4448
2026 Q1	$7.48K	Buy	4,450 +495	+13%	+$2.17K	﹤0.01%	4293
2025 Q4	$20.5K	Buy	3,955 +49	+1%	+$252	﹤0.01%	3424
2025 Q3	$20.4K	Hold	3,906	–	–	﹤0.01%	3029
2025 Q2	$15K	Sell	3,906 -3,000	-43%	-$7.76K	﹤0.01%	2853
2025 Q1	$37.8K	Hold	6,906	–	–	﹤0.01%	2044
2024 Q4	$34.5K	Hold	6,906	–	–	﹤0.01%	1837
2024 Q3	$37.2K	Hold	6,906	–	–	﹤0.01%	1798
2024 Q2	$22.4K	Hold	6,906	–	–	﹤0.01%	1743
2024 Q1	$22.6K	Buy	6,906 +3,901	+130%	+$12.8K	﹤0.01%	1451
2023 Q4	$10.5K	Buy	+3,005	New	+$9.27K	﹤0.01%	1582

Other funds holding ALDX

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Farther Finance Advisors's ALDX Position: Q3 2026 in Review

Farther Finance Advisors reduced its Aldeyra Therapeutics (ALDX) stake by 12% in Q3 2026, selling an estimated $858 and leaving 3,960 shares worth $4.87K. The position accounts for ﹤0.01% of the portfolio, ranked #5026.

Farther Finance Advisors first reported a position in ALDX in Q4 2023 and has held it in 12 quarters since. The position peaked at $37.8K in Q1 2025. 2 funds tracked by Wall St. Rank hold ALDX as of Q3 2026.

Farther Finance Advisors held 3,960 shares of Aldeyra Therapeutics worth $4.87K as of Q3 2026.
Farther Finance Advisors sold 537 Aldeyra Therapeutics shares in Q3 2026, an estimated $858.
Aldeyra Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5026 holding.
Farther Finance Advisors first reported a position in Aldeyra Therapeutics in Q4 2023 and has held it in 12 quarters since.
Farther Finance Advisors's Aldeyra Therapeutics position peaked at $37.8K in Q1 2025.
2 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.